期刊文献+

γ干扰素对高磷诱导大鼠血管平滑肌细胞钙化的影响研究 被引量:10

Effect of IFNγ on high phosphorus-induced calcification in rat vascular smooth muscle cells
下载PDF
导出
摘要 目的探讨γ干扰素(IFNγ)对大鼠血管平滑肌细胞(VSMCs)钙化的影响,为临床治疗血管钙化提供新的线索。方法大鼠胸主动脉VSMCs原代培养,采用免疫细胞化学方法鉴定。将VSMCs随机分为阴性对照组、高磷组、IFNγ干预组(在高磷培养基的基础上加入100 U/L重组大鼠IFNγ),刺激3 d后RT-PCR对各组细胞内核心结合因子α1(Cbfα1)、骨形态发生蛋白2(BMP2)、Smad 1以及Smad 7的mRNA进行检测,刺激14 d后,对各组细胞进行钙化染色,钙含量及碱性磷酸酶(ALP)活性测定。结果与阴性对照组比较,高磷组及IFNγ干预组VSMCs均有钙盐沉积,ALP活性及Cbfα1的mRNA及蛋白表达均增高,BMP 2、Smad 1 mRNA表达也增高(均为P<0.05),与高磷组比较,IFNγ干预组VSMCs的钙盐沉积、ALP活性及Cbfα1 mRNA和蛋白表达均显著降低(均为P<0.05),BMP 2、Smad 1 mRNA表达也降低,而正常组和IFNγ干预组的VSMCs中Smad 7 mRNA表达均高于高磷组(均为P<0.05)。结论 IFNγ对高磷诱导的VSMCs钙化有抑制作用,其可能机制之一是通过抑制了VSMCs Cbfα1的表达,进而抑制了VSMCs的转分化来实现的。 Objective To explore the effect of IFNγ on rat vascular smooth muscle cell ( VSMCs) calcification. Methods VSMCs were obtained from rat aortic, and identified by immunocytochemistry, then randomly divided into control group, high phosphorus group and IFNγ intervention group. Calcification staining, calcium content and alkaline phosphatase activity were measured and the expressions of BMP2, Smad 1 and Cbfa 1 mRNA were detected by RT-PCR and the expression of Cbfa1 protein was detected by western blot, after stimulating 3 days. Results Compared with the control group, the high phosphorus groups cell calcification, alkaline phosphatase activity and the expressions of Cbfa1, BMP2, Smad1 mRNA were increased significantly ( all p 〈 0. 05 ) . Compared with the high phosphorus group, the calcium deposition, ALP activity and the expressions of BMP2,Smad 1 and Runx 2 mRNA in IFNy intervention group were decreased significantly (all p〈0. 05). Conclusions IFNγ can reduce the calcification in rat vascular smooth muscle cells, may be due to inhibiting the transdifferentiation of vascular smooth muscle cells.
出处 《中国心血管杂志》 2015年第1期62-66,共5页 Chinese Journal of Cardiovascular Medicine
基金 河北省自然科学基金(H2012206157)~~
关键词 β-甘油磷酸盐 血管平滑肌细胞 IFNΓ 钙化 钙含量 β-glycerophosphate Vascular smooth muscle cells IFNγ Calcification Calcium content
  • 相关文献

参考文献19

  • 1Pun PH, Smarz TR, Honeycutt EF, et al. Chronic kidney diseaseis associated with increased risk of sudden cardiac death amongpatients with coronary artery disease[ J]. Kidney Int,2009 ,76 :652-658.
  • 2Kanbay M, Goldsmith D , Uyar ME, et ai. Magnesium in chronickidney disease : challenges and opportunities [ J ]. Blood Purif,2010,29: 280-292.
  • 3Deraer LL, Tintut Y. Inflammatory, metabolic, and geneticmechanisms of vascular calcification [ J ] . Arterioscler ThrombVase Biol, 2014,34;715-723.
  • 4Kelchtermans H, Struyf S, De Klerck B, et al. Protective role ofIFN-gamma in collagen- induced arthritis conferred by inhibitionof mycobacteria- induced granulocyte chemotactic protein- 2production^ J]. J Leukoc Biol, 2007 , 81: 1044-1053.
  • 5Idelevich A, Rais Y, Monsonego-Oman E. Bone Gla proteinincreases HIF-1 alpha-dependent glucose metabolism and inducescartilage and vascular calcification[ J]. Arterioscler Thromb VaseBiol, 2011,31:e55-71.
  • 6Aoshima Y,Mizobuchi M, Ogata H, et al. Vitamin D receptoractivators inhibit vascular smooth muscle cell mineralizationinduced by phosphate and TNF-a[ J]. Nephrol Dial Transplant,2012,27:18004806.
  • 7Louvet L, Biichel J,Steppan S, et al. Magnesium preventsphosphate-induced calcification in human aortic vascular smoothmuscle cells[ J]. Nephrol Dial Transplant,2013, 28: 869-878.
  • 8Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidneydisease in China: a cross-sectional survey [ J ]. Lancet, 2012,379:815-822.
  • 9Covic A, Kanbay Met. Vascular calcification in chronic kidneydisease[ J]. Clin Sci (Lond) ,2010,119 :111-121.
  • 10Catherine MS, Crouthamel MH,Kapustin A, et al. Arterialcalcification in chronic kidney disease: key roles for calcium andphosphate [ J]. Circ Res, 2011 ,109 :697-711.

同被引文献88

  • 1钟慧,李带瑛,王苏樱,陈洁仪,陈佳欣,谭笑,王月恒,谢宇晨,朱东兴.丹参酮Ⅱa通过NF-κB和β-catenin信号通路抑制血管钙化[J].生理学报,2022,74(6):949-958. 被引量:15
  • 2陈泽君,黄颂敏,樊文星,唐万欣,刘芳,邱红渝.高糖刺激血管平滑肌细胞表达cbfα-1和OC的实验研究[J].四川大学学报(医学版),2010,41(5):784-788. 被引量:3
  • 3李琨,顾勇,赖凌云,刘少军,郝传明,林善锬.慢性代谢性酸中毒显著诱导大鼠系膜细胞的增殖[J].中国病理生理杂志,2005,21(8):1514-1519. 被引量:2
  • 4Mclntyre NJ, Fluck ILl, McIntyre CW, et al. Determinants of arterial stiffness in chronic kidney disease stage 3 [J]. PLoS One, 2013, 8 (1) : e55444.
  • 5Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification [J]. Arterioscler Thromb Vasc Biol, 2014, 34 (4): 715-723.
  • 6Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: Key roles for calcium and phosphate [J]. Circ Res, 2011, 109 (6): 697-711.
  • 7Godfraind T. Calcium channel blockers in cardiovascular pharmacotherapy [ J]. J Cardiovasc Pharmacol Ther, 2014, 19 (6) : 501 -515.
  • 8Schraven E, Trottnow D, Nitz RE. Inhibition of vitamin D3 - induced vascular calcification by carbocromen [ J]. Adv Myoeardiol, 1983, : 263 -267.
  • 9Chen NX, Kircelli F, O'Neill KD, et al. Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells [J]. Kidney Int, 2010, 77 (5): 436-442.
  • 10Karohl C, D'Marco Gasc6n L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease [ J ]. Nat Rev Nephrol, 2011, 7 (10): 567-577.

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部